Clinical Validation and FDA Regulatory Affairs
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract for Clinical Validation and FDA Regulatory Affairs supports prime contractors on ARPA-H REST projects within the Department of Health and Human Services. The scope of work involves the design and management of pilot and pivotal FDA trials, including patient recruitment and the analysis of clinical data to ensure specific AUC and sensitivity metrics are met. The selected provider must adhere to Good Clinical Practice and FDA regulatory submission standards to deliver comprehensive clinical trial reports, validated performance data, and FDA submission dossiers. The opportunity was posted on September 14, 2026, with a response deadline of October 13, 2026, under NAICS code 541611.
General Info
Agency
NAICS
Place of Performance
DCSet-Aside
Documents
This scope was carved out of ARPA-H-SOL-26-159.
The full solicitation package (10 documents), including the RFP, is on the prime solicitation, not on this scope.
Restorative and health-Enhancing Sleep Time (REST)
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
